Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 6, 2025
Many Americans Want to Keep Their Natural Teeth—But Aren’t Taking the Right Steps
GlobeNewswire
·
May 6, 2025
CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Americans overwhelmingly want to keep their natural teeth for their lifetime. But a new survey from the American Association of Endodontists reveals a disconnect between that goal and the daily habits needed to …
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
GlobeNewswire
·
May 6, 2025
The WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients. Approval was supported by superior 12-month target lesion primary patency (70.1%) and access circuit primary patency (58.1%) in the randomized arm …
Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13
GlobeNewswire
·
May 6, 2025
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the first …
Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical
GlobeNewswire
·
May 6, 2025
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced that the dispute between Route 92 …
Imprivata Wins Global InfoSec Awards in Passwordless Authentication and Third Party Risk Categories
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for life- and mission-critical industries, today announced that the company has won two Global InfoSec Awards 2025, presented by Cyber Defense Magazine during RSA …
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
GlobeNewswire
·
May 6, 2025
Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, hard-to-treat cancers Ongoing pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin for the treatment of acute …
Earth Science Tech, Inc. Annual Shareholder Letter FY Ending 03/31/2025
GlobeNewswire
·
May 6, 2025
Miami, FL, May 06, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. …
SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
GlobeNewswire
·
May 6, 2025
TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. …
Digital Utilities Ventures CEO Mark Gaalswyk Meets with QFFD in Qatar
GlobeNewswire
·
May 6, 2025
Strategic Partnership with QFFD to Transform Agriculture and Water Sustainability in Africa: Easy Environmental Solutions, Inc. (OTC: DUTV) is actively engaging with the Qatar Fund for Development (QFFD) and multiple African governments to launch scalable …
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
GlobeNewswire
·
May 6, 2025
VANCOUVER, Washington, May 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that …
Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois
GlobeNewswire
·
May 6, 2025
LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has …
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
GlobeNewswire
·
May 6, 2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Alpha Tau to Participate in May Investor Conferences
GlobeNewswire
·
May 6, 2025
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentation in …
Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases
GlobeNewswire
·
May 6, 2025
Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing Phase 1a/b study of PALI-2108 and has …
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
GlobeNewswire
·
May 6, 2025
Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline development NEW YORK, May 06, 2025 ( …
Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 6, 2025
— First quarter revenue of $16.7M, +26% year-over-year growth; IFRS gross margin of 76.3% — First quarter pulse recurring revenue of $7.0M, +49% year-over-year growth — IFRS and non-IFRS operating loss of -$1M and -$0.2M, respectively SAN CLEMENTE, Calif., …
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
May 6, 2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …
UMeWorld Releases Clinical Results: DAG Oil Shows Significant Reductions in Uric Acid, Cholesterol, Triglycerides, and Weight
GlobeNewswire
·
May 6, 2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) today announced the results of a clinical study demonstrating the metabolic benefits of diacylglycerol (DAG) oil, the active ingredient in its functional cooking oil brand, DAGola. The …
Nova Leap Health Corp. announces Closing of Home Care Acquisition in Nova Scotia
GlobeNewswire
·
May 6, 2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 06, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a growing home health care organization, is …
Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US
GlobeNewswire
·
May 6, 2025
WARRINGTON, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …